K Number
K023744
Date Cleared
2003-01-03

(57 days)

Product Code
Regulation Number
862.1215
Panel
CH
Reference & Predicate Devices
N/A
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

The "Wiener lab. CK-MB DS UV unitest" test system is a quantitative in vitro diagnostic device intended to measure the activity of the MB isoenzyme of creatine phosphokinase in plasma and serum. Measurements of creatine phosphokinase and its isoenzymes are used in the diagnosis and treatment of myocardial infarction and muscle diseases such as progressive, Duchenne-type muscular dystrophy.

Device Description

Not Found

AI/ML Overview

I am sorry, but the provided text does not contain the detailed study information, acceptance criteria, or device performance metrics needed to answer your request. The document is a 510(k) clearance letter from the FDA for a device called "Weiner lab. CK-MB DS UV unitest," which is a creatine phosphokinase/creatine kinase or isoenzymes test system.

While it mentions the device's intended use and substantial equivalence to a predicate device, it does not include:

  • A table of acceptance criteria and reported device performance.
  • Details about specific studies, such as sample sizes, data provenance, ground truth establishment, or expert qualifications.
  • Information regarding MRMC comparative effectiveness studies or standalone algorithm performance.

The letter is primarily a regulatory communication indicating that the device has met the requirements for market clearance, not a technical report detailing performance study results.

§ 862.1215 Creatine phosphokinase/creatine kinase or isoenzymes test system.

(a)
Identification. A creatine phosphokinase/creatine kinase or isoenzymes test system is a device intended to measure the activity of the enzyme creatine phosphokinase or its isoenzymes (a group of enzymes with similar biological activity) in plasma and serum. Measurements of creatine phosphokinase and its isoenzymes are used in the diagnosis and treatment of myocardial infarction and muscle diseases such as progressive, Duchenne-type muscular dystrophy.(b)
Classification. Class II.